A Study on SANGUINATE™ for the Reduction of Delayed Graft Function in Kidney Transplant Patients
Clinical trial NCT02658162 · WITHDRAWN
Trial details
- NCT number
- NCT02658162
- Sponsor
- Prolong Pharmaceuticals
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-01
- Primary completion
- 2018-10-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.